- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Camostat.
Displaying page 1 of 1.
EudraCT Number: 2020-002110-41 | Sponsor Protocol Number: CRUKD/20/002 | Start Date*: 2020-06-18 | |||||||||||
Sponsor Name:Cancer Research UK | |||||||||||||
Full Title: SPIKE-1 TRIAL: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated memb... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002233-15 | Sponsor Protocol Number: NICCAM-001 | Start Date*: 2020-06-17 | |||||||||||
Sponsor Name:Charité Research Organisation GmbH | |||||||||||||
Full Title: A randomized, single blind, placebo-controlled, multiple dose, parallel-arm study to investigate the safety and preliminary efficacy of the combination of Niclosamide and Camostat to treat COVID-19... | |||||||||||||
Medical condition: SARS-Coronavirus 2 disease 2019 (COVID-19) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003366-39 | Sponsor Protocol Number: APHP200702 | Start Date*: 2020-10-16 |
Sponsor Name:Assitance Publique-Hopiaux de Paris | ||
Full Title: CAMOVID: A multicenter randomized trial to evaluate the efficacy and safety of camostat mesylate for the treatment of SARS-CoV-2 infection in ambulatory adult patients. | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003475-18 | Sponsor Protocol Number: COV-AAT | Start Date*: 2020-10-21 |
Sponsor Name:Ghent University Hospital | ||
Full Title: The potential of oral Camostat in early COVID-19 disease in an ambulatory setting to reduce viral load and disease burden. | ||
Medical condition: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001200-42 | Sponsor Protocol Number: CamoCO-19-001 | Start Date*: 2020-03-30 | |||||||||||
Sponsor Name:Department of Infecitous Diseases, Aarhus University Hospital | |||||||||||||
Full Title: The Impact of Camostat Mesilate on COVID-19 Infection: An investigator-initiated randomized, placebo-controlled, phase IIa trial | |||||||||||||
Medical condition: 2019-nCoV acute respiratory disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004695-18 | Sponsor Protocol Number: RES-Q-HR | Start Date*: 2020-12-02 | ||||||||||||||||||||||||||
Sponsor Name:Heinrich-Heine-University Düsseldorf | ||||||||||||||||||||||||||||
Full Title: Reconvalescent plasma/Camostat mesylate early in Sars-CoV-2 Q-PCR positive high risk individuals | ||||||||||||||||||||||||||||
Medical condition: The novel coronavirus designated SARS CoV-2, and the disease caused by this virus designated COVID-19. No treatment is available for early disease stages and non-hospitalized patients to date. This... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005911-27 | Sponsor Protocol Number: S64445 | Start Date*: 2021-03-17 |
Sponsor Name:KU Leuven | ||
Full Title: The DAWN antivirals trial: the efficacy of antivirals for COVID-19 infections presenting to ambulatory care: a randomized controlled trial. | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.